Jazz Pharmaceuticals CCO Samantha Pearce to retire by June 30, 2027, or upon successor appointment
JAZZ•Jazz Pharmaceuticals EVP and Chief Commercial Officer Samantha Pearce plans to retire when a successor is appointed or by June 30, 2027, whichever comes first; the company will begin a search spanning internal and external candidates.
1. Retirement plans
Jazz Pharmaceuticals said EVP and Chief Commercial Officer Samantha Pearce notified the company that she plans to retire from the role. Her retirement is set for the earlier of a successor’s appointment or June 30, 2027, and the company plans to begin a formal search covering internal and external candidates.
